QUU
2 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Simple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical Samples
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3046
- Medical specialty
- Microbiology
- FDA definition
- A simple in vitro diagnostic device for the detection of secreted proteins from Bacillus species (spp.) is a prescription in vitro diagnostic device used to detect and presumptively identify B. anthracis and other Bacillus spp. in human clinical samples as an aid in the diagnosis of anthrax and other diseases caused by Bacillus spp. This device is simple to use and does not involve sample manipulation or measurement of an analyte that could be affected by conditions such as sample turbidity or cell lysis. This device may be used to aid in the presumptive diagnosis of anthrax in individuals who have signs and symptoms consistent with anthrax and a likelihood of exposure. Bacillus infections include anthrax (cutaneous, inhalational, or gastrointestinal) caused by B. anthracis, gastrointestinal disease, non-gastrointestinal infections, and an anthrax-like illness caused by B. cereus.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| The SensiTox B. anthracis Toxin Test (K232545) | First Light Diagnostics, Inc. | 2023-11-20 |
| Active Anthrax DetectTM Plus Rapid Test (DEN220044) | InBios International, Inc. | 2023-02-03 |
Track QUU automatically
Every clearance here is in the API, with alerts when new ones post.